Protecting Cardiovascular Health From Wildfire Smoke.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
06 09 2022
Historique:
entrez: 6 9 2022
pubmed: 7 9 2022
medline: 9 9 2022
Statut: ppublish

Résumé

Wildfire smoke is a rapidly growing threat to global cardiovascular health. We review the literature linking wildfire smoke exposures to cardiovascular effects. We find substantial evidence that short-term exposures are associated with key cardiovascular outcomes, including mortality, hospitalization, and acute coronary syndrome. Wildfire smoke exposures will continue to increase over the majority of Earth's surface. For example, the United States alone has experienced a 5-fold increase in annual area burned since 1972, with 82 million individuals estimated to be exposed to wildfire smoke by midcentury. The associated rise in excess morbidity and mortality constitutes a growing global public health crisis. Fortunately, the effect of wildfire smoke on cardiovascular health is modifiable at the individual and population levels through specific interventions. Health systems therefore have an opportunity to help safeguard patients from smoke exposures. We provide a roadmap of evidence-based interventions to reduce risk and protect cardiovascular health. Key interventions include preparing health systems for smoke events; identifying and educating vulnerable patients; reducing outdoor activities; creating cleaner air environments; using air filtration devices and personal respirators; and aggressive management of chronic diseases and traditional risk factors. Further research is needed to test the efficacy of interventions on reducing cardiovascular outcomes.

Identifiants

pubmed: 36067276
doi: 10.1161/CIRCULATIONAHA.121.058058
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0
Smoke 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

788-801

Auteurs

Michael B Hadley (MB)

Icahn School of Medicine at Mount Sinai, New York, NY (M.B.H.).

Sarah B Henderson (SB)

British Columbia Centre for Disease Control, Vancouver, Canada (S.B.H.).
University of British Columbia, Vancouver, Canada (S.B.H., M.B.).

Michael Brauer (M)

University of British Columbia, Vancouver, Canada (S.B.H., M.B.).
Institute for Health Metrics and Evaluation, University of Washington, Seattle (M.B.).

Rajesh Vedanthan (R)

New York University Grossman School of Medicine (R.V.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH